Guardant Health Inc
NASDAQ:GH
Guardant Health Inc
Revenue
Guardant Health Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guardant Health Inc
NASDAQ:GH
|
Revenue
$563.9m
|
CAGR 3-Years
25%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$360.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Cigna Corp
NYSE:CI
|
Revenue
$206B
|
CAGR 3-Years
8%
|
CAGR 5-Years
22%
|
CAGR 10-Years
20%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
Guardant Health Inc
Revenue Breakdown
Breakdown by Geography
Guardant Health Inc
Total Revenue:
563.9m
USD
|
United States:
526.5m
USD
|
International:
37.4m
USD
|
Breakdown by Segments
Guardant Health Inc
See Also
What is Guardant Health Inc's Revenue?
Revenue
563.9m
USD
Based on the financial report for Dec 31, 2023, Guardant Health Inc's Revenue amounts to 563.9m USD.
What is Guardant Health Inc's Revenue growth rate?
Revenue CAGR 5Y
44%
Over the last year, the Revenue growth was 25%. The average annual Revenue growth rates for Guardant Health Inc have been 25% over the past three years , 44% over the past five years .